Edit |   |
---|---|
Antigenic Specificity | Clostridium difficile Toxin B (Bezlotoxumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Bezlotoxumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Clostridium difficile Toxin B, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Bezlotoxumab is a human monoclonal antibody that binds to Clostridium difficile toxin B and neutralizes its effects. Used to reduce the recurrence of Clostridium difficle infection in adults receiving antibiotic therapy to treat C. difficile infection and high risk of recurrence. |
Immunogen | n/a |
Other Names | Bezlotoxumab, Clostridium difficile Toxin B, 1246264-45-8 |
Gene, Accession # | CAS: 1246264-45-8 |
Catalog # | abx831243 |
Price | please inquire |
Order / More Info | Clostridium difficile Toxin B (Bezlotoxumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950